Federal Register / Vol. 75, No. 168 / Tuesday, August 31, 2010 / Notices 53311 

Dated: August 25, 2010. 

Carol Walker, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–21737 Filed 8–30–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30-Day–10–0798] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Health Marketing (OMB No. 0920– 

0798, exp. 01/31/2011)—Extension— 

Office of the Associate Director for 

Communication (OADC), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Today, CDC is globally recognized for 

conducting research and investigations 

and for its action oriented approach. 

CDC applies research and findings to 

improve people’s daily lives and 

responds to health emergencies— 

something that distinguishes CDC from 

its peer agencies. 

CDC is committed to achieving true 

improvements in people’s health. To do 

this, the agency is defining specific 

health protection goals to prioritize and 

focus its work and investments and 

measure progress. 

It is imperative that CDC provide 

high-quality timely information and 

programs in the most effective ways to 

help people, families, and communities 

protect their health and safety. Through 

continuous consumer feedback, 

prevention research, and public health 

information technology, we identify and 

evaluate health needs and interests, 

translate science into actions to meet 

those needs, and engage the public in 

the excitement of discovery and the 

progress being made to improve the 

health of the Nation. In our outreach to 

partners, we build relationships that 

model shared learning, mutual trust, 

and diversity in points of view and 

sectors of society. 

OADC is requesting a 3-year extension 

of OMB 0920–0798, Health Marketing, 

to provide feedback on the 

development, implementation and 

satisfaction regarding public health 

services, products, communication 

campaigns and information. The 

information will be collected using 

standard qualitative and quantitative 

methods such as interviews, focus 

groups, and panels, as well as 

questionnaires administered in person, 

by telephone, by mail, by e-mail, and 

online. More specific types of studies 

may include: User experience and usertesting; concept/product/package 

development testing; brand positioning/ 

identity research; customer satisfaction 

surveying; ethnography/observational 

studies; and mystery shopping. The data 

will be used to provide input to the 

development, delivery and 

communication of public health 

services and information at CDC and to 

address emerging programmatic needs. 

Every National Center and Office at 

CDC will have the opportunity to utilize 

this generic clearance. There is no cost 

to the respondents other than their time. 

The total estimated burden hours are 

11,250. 

Type of respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average burden per response 

(in hours) 

CDC Partners, Public Health Professionals, Health Care Professionals, General Public .......... 25,000 1 27/60 

Dated: August 24, 2010. 

Maryam I. Daneshvar, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2010–21736 Filed 8–30–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30-Day–10–0736] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Human Smoking Behavior Study— 

Reinstatement with Change—National 

Center for Chronic Disease Prevention 

and Health Promotion (NCCDPHP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Cigarettes have been ranked as fullflavor, light or ultralight on the basis of 

machine-measured levels of smoke 

toxins (yield categories). The machinebased methods approximate human 

smoking patterns under controlled 

conditions but may not accurately 

reflect conditions of actual use, 

moreover, public health data have not 

consistently shown differences in health 

outcomes among smokers of cigarettes 

of different machine-smoked yield 

categories. 

In 2007, the Centers for Disease 

Control and Prevention (CDC) received 

OMB approval for a research study 

designed to elucidate patterns of human 

smoking behavior, quantify biomarkers 

of exposure to smoke toxins under 

conditions of actual use, and assess how 

smoking behavior modifies the 

relationship between cigarette yield 

category, biomarkers of exposure, and 

measures of cardiovascular reactivity 

(OMB No. 0920–0736, exp. 3/31/2010). 

The study was initiated collaboratively 

by the National Center for Chronic 

Disease Prevention and Health 

Promotion (NCCDPHP) and the National 


srobinson on DSKHWCL6B1PROD with NOTICES
53312 Federal Register / Vol. 75, No. 168 / Tuesday, August 31, 2010 / Notices 

Center for Environmental Health 

(NCEH). Information was collected from 

adult smokers of full-flavor, light and 

ultralight cigarettes, however, the target 

number of respondents was not 

achieved during the initial project 

period. 

CDC requests OMB approval to 

reinstate the information collection in 

order to meet recruitment goals and 

complete the data analysis as planned. 

Changes include a reduction in the 

number of respondents and a 

corresponding reduction in the total 

estimated burden hours. In addition, 

minor changes will be made to account 

for changes in cigarette labels, which no 

longer use descriptors such as fullflavor, light or ultralight. There are no 

changes to the data collection 

instruments or the estimated burden per 

response. 

Respondents will be asked to 

participate in a descriptive study of 

smoking behavior that involves two 

laboratory visits. Established smokers 

who are interested in participating will 

be screened for eligibility during a brief 

five-minute computer-assisted 

telephone interview (CATI). We 

estimate screening approximately 150 

individuals annually to yield complete 

data collection on the annualized goal of 

61 respondents. After completing the 

CATI, individuals who express 

continued interest in study participation 

will undergo five additional minutes of 

eligibility screening at the first 

laboratory visit. 

Each respondent who enrolls in the 

study will make two one-hour visits to 

an assessment laboratory. The visits will 

occur on two consecutive days: Visit 1 

will be scheduled in the morning of the 

first day, and Visit 2 will be scheduled 

in the afternoon of the second day. 

Samples, measurements, and behavioral 

information will be collected at each 

visit. Visit 1 will include biologic 

sample collection (urine, saliva, breath 

carbon monoxide), smoking behavior of 

smoking one cigarette, ventilation hole 

blocking procedure and breath 

measurements. Visit 2 will include 

discussion of quit opportunities if 

requested, biologic sample collection 

(urine, saliva, breath carbon monoxide), 

smoking behavior of smoking one 

cigarette, ventilation hole blocking 

procedure and breath measurements. In 

addition, at Visit 2, each respondent 

will submit the cigarette butts of all 

cigarettes smoked since Visit 1 and a 

completed Smoking Diary Form. The 

estimated burden for the Smoking Diary 

Form is ten minutes. 

The goals of this project are to 

characterize the range of human 

smoking behavior for a variety of 

cigarette categories and machinesmoked yields, and to estimate the 

levels of biomarkers of exposure with 

the various cigarette styles. 

OMB approval is requested for two 

years. Participation in the study is 

voluntary. There are no costs to 

respondents other than their time. The 

total estimated burden hours are 151. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Adult Smokers ......................................................................... CATI Screener ....................... 150 1 5/60 

Visit 1 Screener ...................... 70 1 5/60 

Smoking Diary ........................ 61 1 10/60 

Laboratory Visit ...................... 61 2 1 

Dated: August 23, 2010. 

Maryam I. Daneshvar, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2010–21723 Filed 8–30–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0417] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Experimental 

Study of Format Variations in the Brief 

Summary of Direct-to-Consumer Print 

Advertisements 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the Experimental Study of Format 

Variations in the Brief Summary of 

Direct-to-Consumer (DTC) Print 

Advertisements (ads). This study is 

designed to test different ways of 

presenting benefit and risk information 

in the brief summary in DTC print ads. 

DATES: Submit either electronic or 

written comments on the collection of 

information by November 1, 2010. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http:// 

www.regulations.gov. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: 

Elizabeth Berbakos, Office of 

Information Management, Food and 

Drug Administration, 1350 Piccard Dr., 

PI50–400B, Rockville, MD 20850, 301– 

796–3792, 

Elizabeth.Berbakos@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA (44 U.S.C. 3501–3520), Federal 

agencies must obtain approval from the 

Office of Management and Budget 

(OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ is defined in 

44 U.S.C. 3502(3) and 5 CFR 1320.3(c) 

and includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires Federal agencies 

to provide a 60-day notice in the 

Federal Register concerning each 

proposed collection of information 

before submitting the collection to OMB 

for approval. To comply with this 

requirement, FDA is publishing notice 

of the proposed collection of 

information set forth in this document. 


srobinson on DSKHWCL6B1PROD with NOTICES